Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer | 10 |
Aylık toplam ziyaret
| views | |
|---|---|
| Mart 2026 | 0 |
| Nisan 2026 | 0 |
| Mayıs 2026 | 1 |
| Haziran 2026 | 1 |
| Temmuz 2026 | 0 |
| Ağustos 2026 | 0 |
| Eylül 2026 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Presence of BRCA mutations and a pre_chemotherapy AMH level of 2NG_ML strongly predict risk of amenorrhea in women with breast cancer.pdf | 2 |
